Testing Nucleo CMP Forte for treating pediatric traumatic brain injuries
Official title: Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics: A Randomized Controlled Trial
Run by Tanta University · NCT04499755 · Data updated 2026-11-12
This study is testing if Nucleo CMP Forte can help children with moderate to severe traumatic brain injuries recover better.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | Any age to 18 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta) |
| Status | Recruiting |
| Started | June 1, 2020 |
| Main results expected | December 1, 2030 |
| Study ends | December 10, 2030 |
| Registry record updated | August 5, 2020 |
| Trial ID | NCT04499755 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children diagnosed with moderate to severe traumatic brain injuries.
✕Probably not a fit
Patients with underlying central nervous system disorders may not benefit from this treatment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the efficacy of Nucleo CMP Forte in children suffering from moderate to severe traumatic brain injuries. It is a Phase 3 interventional trial that aims to determine how well this treatment works in improving outcomes for pediatric patients. The study will involve administering Nucleo CMP Forte and monitoring its effects on recovery and brain function. The goal is to provide evidence for its effectiveness in this vulnerable population.
Why it matters
Potential benefit: If successful, this treatment could significantly improve recovery outcomes for children with traumatic brain injuries.
How similar studies have gone: There is limited information on similar studies, making this approach relatively novel in the context of pediatric traumatic brain injury.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children with traumatic brain injury: Moderate and Severe. Exclusion Criteria: * Underlying CNS disorders,
Where it's running
-
Sherief Abd-Elsalam
Tanta, Egypt Recruiting
Study contacts
- Principal investigator: Abeer Salamah, Lecturer — Pediatrics department - Kafr-Elsheikh University
- Study coordinator: Sherief Abd-Elsalam, ass. prof.
- Email: sheriefabdelsalam@yahoo.com
- Phone: 00201147773440
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Co-designed wrist-hand orthosis for children with neuromotor disorders
In children aged 6 to 14 with neuromotor conditions after brain injury, researchers are testing a wrist-hand brace designed with input from the kids to see if it fits better and is easier to use than their current orthosis.
-
Portable MRI for kids with hypoxic brain injury
This study tests whether a bedside, low-field portable MRI can accurately detect hypoxic-ischemic brain injuries in children compared with standard imaging.
-
Monitoring beta-lactam antibiotics and kidney clearance in ICU patients with acute brain injury
This project tries to see if checking kidney clearance together with blood drug levels can quickly identify ICU patients with acute brain injury who need higher doses of beta-lactam antibiotics.
-
Biofeedback training for vision loss after brain injury
This study is testing if biofeedback training can help people with vision loss from brain injuries see better and improve their quality of life.
-
Evaluation of patients with traumatic and hypoxic-ischemic brain injuries
This study is trying to understand how brain injuries from trauma or lack of oxygen affect kids and young adults under 20, to find better ways to help them.
-
Prebiotic treatment to improve gut health and brain function after injury
This study is testing if a type of dietary fiber called Inulin can improve gut health and help reduce fatigue and cognitive problems in people recovering from brain injuries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.